10 Recruiting Primary Central Nervous System Lymphoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Primary Central Nervous System Lymphoma
Related Conditions
Top Recruiting Primary Central Nervous System Lymphoma Studies
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Acalabrutinib and Durvalumab in Primary and Secondary Central Nervous System Lymphoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Pembrolizumab, Ibrutinib and Rituximab in PCNSL
📍 Dana Farber Cancer Institute — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas
📍 Miami Cancer Institute at Baptist Health, Inc. — Miami, Florida
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response
📍 Memorial Sloan Kettering Cancer Center — New York, New York
View Study & Checklist ➔